Clark, D W <br/><br/>
Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.  [electronic resource] 

 -  Drug safety  2001 
 - 1143-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0114-5916 
<br/><br/><label>Standard No.: </label>10.2165/00002018-200124150-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Infective Agents--adverse effects<br/>Arrhythmias, Cardiac--chemically induced<br/>Chemical and Drug Induced Liver Injury<br/>Ciprofloxacin--adverse effects<br/>Cohort Studies<br/>Databases, Factual<br/>Drug Monitoring--methods<br/>England--epidemiology<br/>Enoxacin--adverse effects<br/>Family Practice<br/>Female<br/>Humans<br/>Liver Diseases--epidemiology<br/>Male<br/>Middle Aged<br/>Norfloxacin--adverse effects<br/>Ofloxacin--adverse effects<br/>Product Surveillance, Postmarketing--methods<br/>Retrospective Studies<br/>Surveys and Questionnaires<br/>Time Factors